Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer
Status:
Recruiting
Trial end date:
2024-04-22
Target enrollment:
Participant gender:
Summary
Since patients with metastatic pancreatic cancer have a limited life expectancy, it is
important to determine the timing of when to start chemotherapy in order to optimize the
benefits of chemotherapy relative to the side effects. Therefore, two treatment strategies
can be considered: chemotherapy started immediately at diagnosis, or delayed until
disease-related symptoms occur.
Phase:
Phase 3
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)